Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells

Abstract

Despite mechanistic differences, antigp120 and antigp41 antibodies block infectious cell-to-cell HIV transmission. Our data suggest that eliciting high titers of neutralizing antibodies in vivo should be maintained as a main end of HIV vaccine design.